Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572021 · ClinicalTrials.gov registry record · NA
A Comparison of the Outcomes in Fortiva and Strattice Mesh
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05572021: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT05572021 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05572021, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
A comparison of ventral hernia repair with Strattice and Fortiva mesh.Primary The study team aims to determine the hernia recurrence rates for RTI Surgical biologic mesh (Fortiva) compared to Strattice. Also the study team aims to determine the mesh related complications for RTI Surgical biologic mesh (Fortiva) compared to Strattice
Primary Outcome
Frequency of participants with a hernia recurrence
Interventions
- DEVICE Prospective Ventral Hernia Repair with Fortiva
- DEVICE RetroSpective Ventral Hernia Repair with Strattice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2025-03-21 |
| Phase | NA |
Why NCT05572021 stopped before completion
NCT05572021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Prospective Ventral Hernia Repair with Fortiva is the first listed.
NCT05572021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05572021 about?
NCT05572021 is a clinical study titled "A Comparison of the Outcomes in Fortiva and Strattice Mesh". A comparison of ventral hernia repair with Strattice and Fortiva mesh.Primary The study team aims to determine the hernia recurrence rates for RTI Surgical biologic mesh (Fortiva) compared to Strattice. Also the study team aims to determine the mesh related complications for RTI Surgical biologic me...
What is the current status of trial NCT05572021?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2023-09-25. Estimated completion is 2025-03-21.
What interventions are being tested in trial NCT05572021?
The interventions under investigation include: Prospective Ventral Hernia Repair with Fortiva (DEVICE), RetroSpective Ventral Hernia Repair with Strattice (DEVICE).
Who is sponsoring clinical trial NCT05572021?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05572021's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI